4 completed, 1 terminated. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Terminated 1 |
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow Metachromatic Leukodystrophy (MLD): new trials by email Literature Review of Metachromatic Leukodystrophy (MLD) trials Research Report on Metachromatic Leukodystrophy (MLD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy SHP611 - Metachromatic Leukodystrophy (MLD) | Phase 2 | Completed | Shire | 36 | 2019-05-13 | 2026-07-10 |
| An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy HGT-1110 - Metachromatic Leukodystrophy (MLD) | Phase 1 / Phase 2 | Completed | Shire | 24 | 2013-05-23 | 2026-04-21 |
| Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD) Recombinant human arylsulfatase A - Metachromatic Leukodystrophy (MLD) | Phase 1 / Phase 2 | Completed | Shire | 24 | 2012-02-02 | 2021-06-14 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders hematopoietic stem cell infusion - Hurler Syndrome (MPS I), Hurler-Scheie Syndrome | Phase 1 / Phase 2 | Terminated | Talaris Therapeutics Inc. | 3 | 2011-04-01 | 2023-04-12 |
| Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders Campath-1H, Cyclophosphamide, Busulfan - Mucopolysaccharidosis, Hurler Syndrome | Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 46 | 2009-12-01 | 2018-02-05 |
Leukodystrophy, Metachromatic (5) · Adrenoleukodystrophy (2) · Leukodystrophy, Globoid Cell (2) · Mucopolysaccharidosis I (2) · Mucopolysaccharidosis II (2) · alpha-Mannosidosis (2) · Aspartylglucosaminuria (1) · Fucosidosis (1) · Mucopolysaccharidoses (1) · Mucopolysaccharidosis III (1) · Mucopolysaccharidosis VI (1) · Mucopolysaccharidosis VII (1) · Niemann-Pick Diseases (1) · Peroxisomal Disorders (1) · Sandhoff Disease (1)
Brain Diseases (5) · Brain Diseases, Metabolic (5) · Brain Diseases, Metabolic, Inborn (5) · Central Nervous System Diseases (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Demyelinating Diseases (5) · Genetic Diseases, Inborn (5) · Hereditary Central Nervous System Demyelinating Diseases (5) · Leukoencephalopathies (5) · Lipid Metabolism Disorders (5) · Lipid Metabolism, Inborn Errors (5) · Lipidoses (5) · Lysosomal Storage Diseases (5) · Lysosomal Storage Diseases, Nervous System (5) · Metabolic Diseases (5)
Stem Cell Transplantation (2) · Alemtuzumab (1) · Busulfan (1) · Cyclophosphamide (1) · Cyclosporine (1) · Mycophenolic Acid (1)
Shire (3) · Masonic Cancer Center, University of Minnesota (1) · Talaris Therapeutics Inc. (1)
France (3) · Germany (3) · Japan (3) · United States (3) · Australia (2) · Brazil (2) · Denmark (2) · Argentina (1) · Belgium (1) · Canada (1) · Czechia (1) · Greece (1) · Israel (1) · Italy (1) · Netherlands (1)
Paul Orchard, MD (1) · Suzanne T Ildstad, MD (1)
2018 (1)